A Review of Drug-Induced Hyponatremia

American Journal of Kidney Diseases

Volumn 52, Issue 1, 2008, Pages 144-153

  Liamis, George ^a   Milionis, Haralampos ^a   Elisaf, Moses ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Adverse drug reaction; hyponatremia; sodium homeostasis; syndrome of inappropriate secretion of antidiuretic hormone; water homeostasis

Indexed keywords

AMIODARONE; AMPHETAMINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIC AGENT; PROTON PUMP INHIBITOR; THEOPHYLLINE; VASOPRESSIN;

DRUG-INDUCED HYPONATREMIA; ELECTROLYTE DISTURBANCE; FLUID BALANCE; HOMEOSTASIS; HORMONE RELEASE; INCIDENCE; KIDNEY TUBULE; MEDICAL INFORMATION; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SODIUM BALANCE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; FEMALE; GREECE; HUMANS; HYPONATREMIA; INCIDENCE; MALE; PHARMACEUTICAL PREPARATIONS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 45449087534     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.03.004     Document Type: Review

References (94)

1. Anderson R.J., Chung H.M., Kluge R., and Schrier R.W. Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102 (1985) 164-168
2. Arieff A.I., Llach F., and Massry S.G. Neurological manifestations and morbidity of hyponatremia: Correlation with brain water and electrolytes. Medicine (Baltimore) 55 (1976) 121-129
3. Gross P.A., Ketteler M., Hausmann C., and Ritz E. The chartered unchartered waters of hyponatremia. Kidney Int Suppl 21 (1987) S67-S75
4. Arieff A.I. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med 314 (1986) 1529-1535
5. Berl T. Treating hyponatremia: Damned if we do and damned if we don't. Kidney Int 37 (1990) 1006-1018
6. Ellis S.J. Severe hyponatraemia: Complications and treatment. QJM 88 (1995) 905-909
7. Lauriat S.M., and Berl T. The hyponatremic patient: Practical focus on therapy. J Am Soc Nephrol 8 (1997) 1599-1607
8. Spital A. Diuretic-induced hyponatremia. Am J Nephrol 19 (1999) 447-452
9. Byatt C.M., Millard P.H., and Levin G.E. Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. J R Soc Med 83 (1990) 704-708
10. Liamis G., Christidis D., Alexandridis G., Bairaktari E., Madias N., and Elisaf M. Uric acid homeostasis in the evaluation of diuretic-induced hyponatremia. J Investig Med 55 (2007) 36-44
11. Friedman E., Shadel M., Halkin H., and Farfel Z. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med 110 (1989) 24-30
12. Ashraf N., Locksley R., and Arieff A.I. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 70 (1981) 1163-1168
13. Ashouri O.S. Severe diuretic-induced hyponatremia in the elderly. A series of eight patients: Arch Intern Med 146 (1986) 1355-1357
14. Sonnenblick M., Friedlander Y., and Rosin A.J. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 103 (1993) 601-606
15. Abramow M., and Cogan E. Clinical aspects and pathophysiology of diuretic-induced hyponatremia. Adv Nephrol Necker Hosp 13 (1984) 1-28
16. Clark B.A., Shannon R.P., Rosa R.M., and Epstein F.H. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol 5 (1994) 1106-1111
17. Pinnock C.A. Hyponatraemia associated with hydrochrorothiazide treatment. Br Med J 1 (1978) 48-54
18. Dyckner T., and Wester P.O. Effects of magnesium infusions in diuretic induced hyponatraemia. Lancet 1 8220 (1981) 585-586
19. Chapman M., Hanrahan R., McEwen J., and Marley J. Hyponatremia and hypokalemia due to indapamide. MJA 176 (2002) 219-221
20. Luzecky M.H., Burman K.D., and Schultz E.R. The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration. South Med J 67 (1974) 495-497
21. ten Holt W.L., van Iperen C.E., Schrijver G., and Bartelink A. Severe hyponatremia during therapy with fluoxetine. Arch Intern Med 156 (1996) 681-682
22. Jackson C., Carson W., Markowitz J., and Mintzer J. SIADH associated with fluoxetine and sertraline therapy. Am J Psychiatry 152 (1995) 809-810
23. Liu B.A., Mittmann N., Knowles S.R., and Shear N.H. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: A review of spontaneous reports. CMAJ 155 (1996) 519-527
24. Jacob S., and Spinler S.A. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother 40 (2006) 1618-1622
25. Movig K.L., Leufkens H.G., Lenderink A.W., et al. Association between antidepressant drugs and hyponatremia: A case-control study. Br J Clin Pharmacol 53 (2002) 363-369
26. Peterson J.C., Pollack R.W., Mahoney J.J., and Fuller T.J. Inappropriate antidiuretic hormone secondary to a monamine oxidase inhibitor. JAMA 239 (1978) 1422-1423
27. Vincent F.M., and Emery S. Antidiuretic hormone syndrome and thioridazine. Ann Intern Med 89 (1978) 147-148
28. Rao K.J., Miller M., and Moses A. Water intoxication and thioridazine (Mellaril). Ann Intern Med 82 (1975) 61
29. Peck V., and Shenkman L. Haloperidol-induced syndrome of inappropriate secretion of antidiuretic hormone. Clin Pharmacol Ther 26 (1979) 442-444
30. Meinders A.E., Cejka V., and Robertson G.L. The antidiuretic action of carbamazepine in man. Clin Sci Mol Med 47 (1974) 289-299
31. Gold P.W., Robertson G.L., Ballenger J.C., et al. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab 57 (1983) 952-957
32. Flegel K.M., and Cole C.H. Inappropriate antidiuresis during carbamazepine treatment. Ann Intern Med 87 (1977) 722-723
33. Van Amelsvoort T., Bakshi R., Devaux C.B., and Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: A review. Epilepsia 35 (1994) 181-188
34. Kuz G.M., and Manssourian A. Carbamazepine-induced hyponatremia: Assessment of risk factors. Ann Pharmacother 39 (2005) 1943-1946
35. Holtschmidt-Taschner B., and Soyka M. Hyponatremia-induced seizure during carbamazepine treatment. World J Biol Psychiatry 8 (2007) 51-53
36. Dong X., Leppik I.E., White J., and Rarick J. Hyponatremia from oxcarbazepine and carbamazepine. Neurology 65 (2005) 1976-1978
37. Nielsen O.A., Johannessen A.C., and Bardrum B. Oxcarbazepine-induced hyponatremia, A cross-sectional study. Epilepsy Res 2 (1988) 269-271
38. Ikeda K., Moriyasu H., Yasaka M., Oita J., and Yamaguchi T. Valproate related syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-A case report. Rinsho Shinkeigaku 34 (1994) 911-913
39. Robertson G.L., Bhoopalam N., and Zelkowitz L.J. Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone. Arch Intern Med 132 (1973) 717-720
40. RaviKumar T.S., and Grage T.B. The syndrome of inappropriate antidiuretic hormone secretion secondary to vinblastine-bleomycin therapy. J Surg Oncol 24 (1983) 242-245
41. Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer 15 (2007) 1341-1347
42. Berghmans T. Hyponatremia related to medical anticancer treatment. Support Care Cancer 4 (1996) 341-350
43. Lee Y.K., and Shin D.M. Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer. Korean J Intern Med 7 (1992) 118-121
44. Giaccone G., Donadio M., Ferrati P., et al. Disorders of serum electrolytes and renal function in patients treated with cis-platinum on an outpatient basis. Eur J Cancer Clin Oncol 21 (1985) 433-437
45. DeFronzo R.A., Braine H., Colvin M., and Davis P.J. Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation. Ann Intern Med 78 (1973) 861-869
46. Bressler R.B., and Huston D.P. Water intoxication following moderate-dose intravenous cyclophosphamide. Arch Intern Med 145 (1985) 548-549
47. Harlow P.J., DeClerck Y.A., Shore N.A., Ortega J.A., Carranza A., and Heuser E. A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer 44 (1979) 896-898
48. Greenbaum-Lefkoe B., Rosenstock J.G., Belasco J.B., Rohrbaugh T.M., and Meadows A.T. Syndrome of inappropriate antidiuretic hormone secretion. A complication of high-dose intravenous melphalan. Cancer 55 (1985) 44-46
49. Culine S., Ghosn M., and Droz J.P. Inappropriate antidiuretic hormone secretion induced by ifosfamide. Eur J Cancer 26 (1990) 922
50. Frahm H., and von Hulst M. Increased secretion of vasopressin and edema formation in high dosage methotrexate therapy. Z Gesamte Inn Med 43 (1988) 411-414
51. Langfeldt L.A., and Cooley M.E. Syndrome of inappropriate antidiuretic hormone secretion in malignancy: Review and implications for nursing management. Clin J Oncol Nurs 7 (2003) 425-430
52. Mewasingh L., Aylett S., Kirkham F., and Stanhope R. Hyponatraemia associated with lamotrigine in cranial diabetes insipidus. Lancet 356 (2000) 656
53. Weissman P.N., Shenkman L., and Gregerman R.I. Chlorpropamide hyponatremia: Drug-induced inappropriate antidiuretic-hormone activity. N Engl J Med 284 (1971) 65-71
54. Kadowaki T., Hagura R., Kajinuma H., Kuzuya N., and Yoshida S. Chlorpropamide-induced hyponatremia: Incidence and risk factors. Diabetes Care 6 (1983) 468-471
55. Moses A.M., Fenner R., Schroeder E.T., and Coulson R. Further studies on the mechanism by which chlorpropamide alters the action of vasopressin. Endocrinology 111 (1982) 2025-2030
56. Moses A.M., Howanitz J., and Miller M. Diuretic action of three sulfonylurea drugs. Ann Intern Med 78 (1973) 541-544
57. Petersson I. Water intoxication associated with nonsteroidal anti-inflammatory drug therapy. Acta Med Scand 221 (1987) 221-228
58. Webberley M.J., and Murray J.A. Life-threatening acute hyponatremia induced by low dose cyclophosphamide and indomethacin. Postgrad Med J 65 (1989) 950-955
59. Page A.J., Reid S.A., Speedy D.B., Mulligan G.P., and Thompson J. Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflammatory drug use in an ultraendurance mountain run. Clin J Sport Med 17 (2007) 43-48
60. Almond C.S., Shin A.Y., Fortescue E.B., et al. Hyponatremia among runners in the Boston Marathon. N Engl J Med 352 (2005) 1550-1556
61. Ranieri P., Franzoni S., Rozzini R., and Trabucchi M. Venlafaxine-induced reset osmostat syndrome: Case of a 79-year-old depressed woman. J Geriatr Psychiatry Neurol 10 (1997) 75-78
62. Izzedine H., Fardet L., Launay-Vacher V., Dorent R., Petitclerc T., and Deray G. Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: Case report and review of the literature. Clin Pharmacol Ther 71 (2002) 503-507
63. Malaterre H.R., Kallee K., and Daver L.M. Hyponatremia and amlodipine therapy. Cardiovasc Drugs Ther 13 (1999) 171-172
64. Palevsky P.M., Rendulic D., and Diven W.F. Maltose-induced hyponatremia. Ann Intern Med 118 (1993) 526-528
65. Daphnis E., Stylianou K., Alexandrakis M., et al. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy. Nephron Clin Pract 106 (2007) c143-c148
66. Holden R., and Jackson M.A. Near-fatal hyponatremic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA). Lancet 347 (1996) 1052
67. Wilkins B. Cerebral oedema after MDMA ("ecstasy") and unrestricted water intake. Hyponatraemia must be treated with low water input. BMJ 313 (1996) 689-690
68. Mori H., Kuroda Y., Imamura S., et al. Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole. Intern Med 42 (2003) 665-669
69. Adler D., Voide C., Thorens J.B., and Desmeules J. SIADH consecutive to ciprofloxacin intake. Eur J Intern Med 15 (2004) 463-464
70. Mitra S., and Basu S. Cefoperazone/sulbactam induced hyponatremia. Indian J Med Sci 60 (2006) 158-159
71. Chitre M.M., and Berenson C.S. Idiosyncratic rifabutin-induced leukopenia and SIADH: Case report and review. Pharmacotherapy 21 (2001) 493-497
72. Shavit E., and Sherer Y. Hyponatremia induced by amiodarone therapy. Isr Med Assoc J 9 (2007) 564-565
73. Somani P., Temesy-Armos P.N., Leighton R.F., Goodenday L.S., and Fraker Jr. T.D. Hyponatremia in patients treated with lorcainide, a new antiarrhythmic drug. Am Heart J 108 (1984) 1443-1448
74. Dirix L.Y., Moeremans C., Fierens H., et al. Symptomatic hyponatremia related to the use of propafenone. Acta Clin Belg 43 (1988) 143-145
75. Liberopoulos E., Alexandridis G., Christidis D., and Elisaf M. SIADH and hyponatremia with theophylline. Ann Pharmacother 36 (2002) 1180-1182
76. Brewster U.C., and Perazella M.A. Proton pump inhibitors and the kidney: Critical review. Clin Nephrol 68 (2007) 65-72
77. Marshall A.W., Jakobovits A.W., and Morgan M.Y. Bromocriptine-associated hyponatraemia in cirrhosis. Br Med J 285 (1982) 1534-1535
78. Douriez E., Mollard P., Laval C., Albengres E., Laporte J.P., and Tillement J.P. Severe hyponatremia after repeated administration of terlipressin. Therapie 48 (1993) 518-519
79. Kruger S., and Lindstaedt M. Duloxetine and hyponatremia: A report of 5 cases. J Clin Psychopharmacol 27 (2007) 101-104
80. Ori Y., Korzets A., Bergman M., Vishelesky G., and Salman H. Hyponatremia after fluorescein angiography. J Am Geriatr Soc 54 (2006) 872-874
81. Bagley S.C., and Yaeger D. Hyponatremia associated with bupropion, a case verified by rechallenge. J Clin Psychopharmacol 25 (2005) 98-99
82. Johnston C., Webb L., Daley J., and Spathis G.S. Hyponatraemia and moduretic-grand mal seizures: A review. J R Soc Med 82 (1989) 479-483
83. Sonnenblick M., and Rosin A.J. Significance of the measurement of uric acid fractional clearance in diuretic induced hyponatremia. Postgrad Med J 62 (1986) 449-452
84. Decaux G., Schlesser M., Coffernils M., et al. Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol 42 (1994) 102-108
85. Raskind M.A., Orenstein H., and Christopher T.G. Acute psychosis, increased water ingestion, and inappropriate antidiuretic hormone secretion. Am J Psychiatry 132 (1975) 907-910
86. Jose C.J., and Perez-Cruet J. Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am J Psychiatry 136 (1979) 221-222
87. Illowsky B.P., and Kirch D.G. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 145 (1988) 675-683
88. Gin H., Lars I., Beauvieux J.M., Morlat P., and Aubertin J. Hyponatremia induced by biguanides. Case report. Presse Med 17 (1988) 591
89. Pittman J.G. Water intoxication due to oxytocin. N Engl J Med 268 (1963) 481
90. Schwartz R.H., and Jones R.W. Transplacental hyponatraemia due to oxytocin. Br Med J 1 6106 (1978) 152-153
91. Feeney J.G. Water intoxication and oxytocin. Br Med J 285 (1982) 243
92. Shepherd L.L., Hutchinson R.J., Worden E.K., Koopmann C.F., and Coran A. Hyponatremia and seizures after intravenous administration of desmopressin acetate for surgical hemostasis. J Pediatr 114 (1989) 470-472
93. Humphries J.E., and Siragy H. Significant hyponatremia following DDAVP administration in a healthy adult. Am J Hematol 44 (1993) 12-15
94. Liamis G., Kalogirou M., Saugos V., and Elisaf M. Therapeutic approach in patients with dysnatraemias. Nephrol Dial Transplant 21 (2006) 1564-1569